Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This study will assess the rates of Sustained Virological Response following anti-viral
therapy with Peg-Interferon plus Ribavirin in patients that have been liver transplanted with
recurrent Hepatitis C and treated with Neoral or tacrolimus.